Dawnrays Pharmaceutical (Holdings) Limited reported an unchanged authorized share capital of HKD 1,000,000,000, comprising 20,000,000,000 ordinary shares at HKD 0.05 par value each, as of January 31, 2026. The total issued shares rose by 200,000 from the prior month to reach 1,503,557,000 shares. This increase stemmed from the exercise of share options under the 2013 Share Option Scheme, which generated proceeds of HKD 180,000. The company confirmed that it continues to meet the applicable public float threshold under relevant listing requirements.